High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Head and Neck Cancer Survivors

Author(s):  
Author(s):  
Amy Fullerton ◽  
Yuhan Mou ◽  
Natalie Silver ◽  
Neil N. Chheda ◽  
Kathryn Hitchcock ◽  
...  

Oral Oncology ◽  
2021 ◽  
Vol 118 ◽  
pp. 105344
Author(s):  
Joanne M. Patterson ◽  
Liya Lu ◽  
Laura-Jayne Watson ◽  
Sam Harding ◽  
Andy R. Ness ◽  
...  

2016 ◽  
Vol 41 (3) ◽  
pp. 241-248 ◽  
Author(s):  
L. Sammut ◽  
L.R. Fraser ◽  
M.J. Ward ◽  
T. Singh ◽  
N.N. Patel

Author(s):  
Kenneth R. Stevens ◽  
Amy Britsch ◽  
William T. Moss

2019 ◽  
Vol 2019 (53) ◽  
Author(s):  
Barbara A Murphy ◽  
Elizabeth Wulff-Burchfield ◽  
Michael Ghiam ◽  
Stewart M Bond ◽  
Jie Deng

Abstract The systemic effects and manifestations of disease and treatment have been of interest for millennium. Until recently, basic and clinical research is just now reaching a watershed. Systemic symptoms usually do not occur in isolation but rather in clusters; however, much of the cutting-edge research pertaining to the etiology, mechanism, manifestations, and moderators of systemic symptoms in humans has been directed at individual symptoms, thus creating silos of knowledge. Breaching these silos and bridging the knowledge from disparate arenas of investigation to build a comprehensive depiction of acute and chronic systemic symptoms has been a challenge. In addition, much of the recent work in systemic symptoms has been conducted in the setting of nonmalignant disease. The degree to which the findings from other chronic disease processes can be translated into the oncologic realm is unknown. This article will explore inflammation as a major contributing factor to systemic symptoms and sickness behavior, discuss the most common manifestations in cancer survivors, and, where available, discuss specific data pertaining to head and neck cancer survivors.


Sign in / Sign up

Export Citation Format

Share Document